Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-Week results of the GO-RAISE study

Jürgen Braun, Atul Deodhar, Robert D. Inman, Désirée Van Der Heijde, Michael Mack, Stephen Xu, Benjamin Hsu

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-Week results of the GO-RAISE study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds